Press releases
- XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country
- Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea
- Antengene To Present One Oral and Four Abstracts at ASCO 2024
- Antengene Announces One Oral and Three Poster Presentations at ASCO 2024
Key statistics
On Monday, Antengene Corporation Ltd (722:STU) closed at 0.076, 4.83% above its 52-week low of 0.0725, set on Jul 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0725 |
---|---|
High | 0.076 |
Low | 0.0725 |
Bid | 0.076 |
Offer | 0.0815 |
Previous close | 0.0735 |
Average volume | 0.00 |
---|---|
Shares outstanding | 674.89m |
Free float | 360.15m |
P/E (TTM) | -- |
Market cap | 438.68m HKD |
EPS (TTM) | -1.01 HKD |
Data delayed at least 15 minutes, as of Jul 22 2024.
More ▼